These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3529708

  • 1. Identification of key antigens of Plasmodium falciparum as vaccine candidates.
    Bushell GR, Cooper JA, Ingram LT, Schofield L, Saul A, Epping RJ, Chiu S, Jelacic S, Upcroft JA.
    P N G Med J; 1986 Mar; 29(1):69-73. PubMed ID: 3529708
    [No Abstract] [Full Text] [Related]

  • 2. [Can malaria be eradicated by vaccination?].
    Stürchler D.
    Schweiz Rundsch Med Prax; 1987 Sep 01; 76(36):975-80. PubMed ID: 3310179
    [No Abstract] [Full Text] [Related]

  • 3. Conserved polypeptides of Plasmodium falciparum as malaria vaccine candidates?
    Herrera S, Herrera MA, Clavijo C, Corredor A, Certa U.
    Acta Leiden; 1991 Sep 01; 60(1):107-10. PubMed ID: 1820697
    [No Abstract] [Full Text] [Related]

  • 4. [Immunology and molecular biology: targetting of a vaccine].
    Perrin LH, Mach B.
    Ther Umsch; 1986 Feb 01; 43(2):148-54. PubMed ID: 3515610
    [No Abstract] [Full Text] [Related]

  • 5. Pf 155, a candidate for a blood stage vaccine in Plasmodium falciparum malaria.
    Berzins K, Perlmann H, Udomsangpetch R, Wåhlin B, Wahlgren M, Troye-Blomberg M, Carlsson J, Björkman A, Perlmann P.
    Dev Biol Stand; 1985 Feb 01; 62():99-106. PubMed ID: 3914427
    [Abstract] [Full Text] [Related]

  • 6. The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation.
    Good MF, Kumar S, Miller LH.
    Immunol Today; 1988 Nov 01; 9(11):351-5. PubMed ID: 3076406
    [No Abstract] [Full Text] [Related]

  • 7. Identification of a peptide sequence of the 25 kD surface protein of Plasmodium falciparum recognized by transmission-blocking monoclonal antibodies: implications for synthetic vaccine development.
    van Amerongen A, Sauerwein RW, Beckers PJ, Meloen RH, Meuwissen JH.
    Parasite Immunol; 1989 Jul 01; 11(4):425-8. PubMed ID: 2674864
    [No Abstract] [Full Text] [Related]

  • 8. [Current state of the studies of malaria vaccine].
    Dzbeński TH.
    Przegl Epidemiol; 1990 Jul 01; 44(3):173-8. PubMed ID: 2084799
    [No Abstract] [Full Text] [Related]

  • 9. Development of asexual erythrocytic malaria vaccines.
    Chulay JD.
    Prog Clin Biol Res; 1989 Jul 01; 313():13-21. PubMed ID: 2675112
    [No Abstract] [Full Text] [Related]

  • 10. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV, Biswas S, Pillai CR, Saxena RK.
    Vaccine; 2008 Aug 18; 26(35):4526-35. PubMed ID: 18590786
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunoprophylaxis of malaria: characterization of a protective surface antigen.
    Nussenzweig RS, Nussenzweig V.
    Harvey Lect; 2008 Aug 18; 78():59-85. PubMed ID: 6151556
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The use of monoclonal antibodies in the study of the immunology of malaria].
    Foster Cuevas M, Favila Castillo L.
    Salud Publica Mex; 1985 Aug 18; 27(3):246-50. PubMed ID: 3901316
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Production of human monoclonal antibodies against various antigens of erythrocyte stages of Plasmodium falciparum].
    Desgranges C, Ploton I, Paire J, Dubois P, Monjour L.
    C R Acad Sci III; 1985 Aug 18; 301(5):219-24. PubMed ID: 3933777
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.